Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bempedoic acid plus statin in hospitalized acute coronary syndrome
IRCT20251121068068N1Phase 4Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Bempedoic acid + statin with Placebo + statin (2 arms). Primary endpoint: LDL-C. Started Dec 2025; status: recruiting.
02
Drugs
bempedoic acid
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on IRCT20251121068068N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251121068068N1.